Table 4.
Descriptive statistics
Measures | Baseline
|
Posttreatment
|
3-Month FU
|
|||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | |
Depression | ||||||
GRID-HAMD | 14.3 | 4.5 | 9.7 | 4.3 | 8.4 | 3.7 |
BDI-II | 15.3 | 7.9 | 12.5 | 4.9 | 12.8 | 7.1 |
HADS-Depression | 7.9 | 4.5 | 5.9 | 4.1 | 6.0 | 3.9 |
Anxiety | ||||||
HADS-Anxiety | 7.1 | 4.1 | 6.1 | 4.0 | 6.3 | 3.7 |
STAI | 46.4 | 13.0 | 43.6 | 8.0 | 44.5 | 9.9 |
OASIS | 5.8 | 3.7 | 4.3 | 3.2 | 6.2 | 4.2 |
QOL (SF-36) | ||||||
Physical function | 68.2 | 16.3 | 71.6 | 15.4 | 71.8 | 18.6 |
Role physical | 58.5 | 27.1 | 64.5 | 23.8 | 68.1 | 26.4 |
Bodily pain | 52.5 | 25.4 | 57.4 | 23.5 | 52.6 | 23.3 |
General health perceptions | 36.2 | 14.5 | 36.6 | 14.1 | 38.7 | 21.0 |
Vitality | 41.1 | 20.6 | 46.3 | 14.2 | 49.0 | 16.8 |
Social functioning | 64.5 | 24.0 | 65.8 | 26.0 | 72.4 | 23.0 |
Role emotional | 64.0 | 23.8 | 73.2 | 23.5 | 70.2 | 23.1 |
Mental health | 61.8 | 17.6 | 68.9 | 12.6 | 66.6 | 16.9 |
L-Dopa | ||||||
L-Dopa equivalence rate (SD) | 447.4 | 283.0 | 441.0 | 265.4 | 435.2 | 254.9 |
Abbreviations: FU, follow-up; SD, standard deviation; GRID-HAMD, GRID-Hamilton Rating Scale for Depression; BDI-II, Beck Depression Inventory-II; HADS, Hospital Anxiety and Depression Scale; STAI, State and Trait Anxiety Inventory; OASIS, Overall Anxiety Severity and Impairment Scale; QOL, quality of life; SF-36, MOS 36-Item Short-Form Health Survey; MOS, Medical Outcomes Study.